A product may be recognizable while its current online documents still need clarification. Align’s standard US capsule page links artwork with one ingredient declaration, while its general FAQ retains different mass and ingredient wording. That discrepancy is especially worth keeping visible when the product is being discussed alongside prescribed care.
The review follows the actual current standard-capsule page and its newly inspected twenty-eight-capsule artwork. It does not cover every Align format or authenticate a delivered box. The care comparison includes Align as a general digestive probiotic, not a supplement specifically established for people using GLP-1 medicines.
The context to retain
A general digestive product, an unresolved formula record and a medicine-related concern are three separate matters.
Read the quantity in the image, not its filename
The official product page links a front image whose filename contains a different count, but the image itself plainly shows twenty-eight capsules. The linked Supplement Facts image also states twenty-eight servings with a one-capsule serving. The visible artwork controls this description; a technical filename is not evidence of a fifty-six-capsule package. No current selected-retailer price or stock was established from the page’s purchase buttons. The appointment guide explains why the exact package record is useful when another person helps with a care discussion. This review can describe the public image, while leaving the identity of an actual supplied package unverified.
The pictured facts are specific about the strain and time point
The inspected panel identifies Bifidobacterium longum subsp. longum 35624 at 10 mg. Its footnote declares one billion CFUs at manufacture and 1×10^7 probiotic cells through the best-by date. These are different stated time points, not two quantities that can be substituted for one another in a comparison. The other ingredients shown are microcrystalline cellulose and hydroxypropyl methylcellulose, with less than two percent magnesium stearate and titanium dioxide for color. These observations describe the pictured preparation; they do not provide a personal amount or prove viability in a delivered lot. NIH’s organism-specific evidence framework remains separate from those label details. NIH
The FAQ discrepancy is not resolved by choosing the newer-looking page
The fresh manufacturer FAQ still describes 4 mg per capsule and separately states that Align contains milk and sodium caseinate. That does not match the 10 mg and other-ingredient wording in the linked facts image. The relationship between the records is unresolved here. Absence of milk wording from that image does not prove an actual package is milk-free or appropriate for an allergy. The instruction-clarification guide explains why a manufacturer should clarify the applicable formula while a care professional addresses individual concerns. A publication should not settle that question by silently discarding whichever record complicates the description. Both current public sources remain visible.
General digestive claims are not a prescription indication
Align’s page markets support for occasional digestive discomfort, gas and bloating. It is not presented here as a GLP-1-branded product or a substitute for medicine-specific care. The symptom-boundaries guide explains why a new concern during treatment cannot be diagnosed from a match between the symptom’s name and a sales claim. NCCIH describes continuing uncertainties in probiotic evidence and cautions against postponing healthcare. A named strain and a history of research do not independently establish a role in every medication user. This review does not convert the manufacturer’s general adjustment language into permission to tolerate severe, persistent or worsening symptoms. NCCIH
Keep endorsement and testing statements attributed
The product page explicitly says its overall star rating is based on incentivized reviews. It also promotes doctor recommendations and claims DNA testing of lots for the named strain. These are seller statements, not independent testing or firsthand outcomes produced by this publication. A star average cannot identify the cause of a person’s current concern, and a claim about organism identity does not establish every clinical outcome or every component of a supplied capsule. The Culturelle review similarly distinguishes the named strain from a personal treatment question. No clinical rank, superiority badge or probability of benefit is assigned to Align on the basis of those promotional records.
The next question may concern information rather than another product
A clinician or pharmacist may need the exact product label and other medicines before considering the reason for adding a supplement. NIA recommends keeping the full record available and asking when instructions are unclear. The prebiotic discussion adds another reason to identify all components: products sold for digestive support can contain different accompanying ingredients. That observation does not imply that a particular ingredient is responsible for a symptom. The useful next question may be which formula record applies, what evidence addresses the intended purpose, or whether the underlying concern needs assessment first. No automatically generated combination or timing advice is offered here. NIA medicines
Commercial contact cannot complete the clinical conversation
The current page provides purchase routes and promotional information, but no transaction, return decision or response time was tested. An unselected retailer’s price would not establish the total for the pictured twenty-eight-capsule record. Those unknowns belong with the seller, alongside clarification of the facts-image/FAQ discrepancy. The fixed care-context records distinguish that work from questions for the prescribing team. NIA supports asking for understandable directions and discussing options, not assuming that all parties have already coordinated care. If a medicine-specific warning requires immediate action, a manufacturer enquiry must not delay it. A clearer product record is helpful; it is not a clinical clearance. Product page NIA decisions
Sources for this article
Align 24/7 Digestive Support Probiotic Supplement | Align Probiotic
Exact standard US page and inspected current 28-capsule/
Checked 2026-09-28
https://www.alignprobiotics.com/en-us/products/probiotics-digestive-support/probiotic-supplementOffice of Dietary Supplements - Probiotics
Same-day federal probiotic nomenclature/
Checked 2026-09-28
https://ods.od.nih.gov/factsheets/Probiotics-HealthProfessional/FAQs | Align Probiotics
Fresh manufacturer FAQ differs from current pictured label: 4 mg and milk/
Checked 2026-09-28
https://www.alignprobiotics.com/en-us/faqProbiotics: Usefulness and Safety
Same-day federal usefulness/
Checked 2026-09-28
https://www.nccih.nih.gov/health/probiotics-usefulness-and-safetyTaking Medicines Safely as You Age
NIA medicine/
Checked 2026-09-28
https://www.nia.nih.gov/health/medicines-and-medication-management/taking-medicines-safely-you-ageDiscussing Health Decisions with Your Doctor
NIA shared decision questions and written directions; not website-generated treatment decisions. Fresh Site50 TinyFish public fetch
Checked 2026-09-28
https://www.nia.nih.gov/health/medical-care-and-appointments/discussing-health-decisions-your-doctor